Non-Hormonal Intravaginal Contraceptive
- User: Female
- Hormonal: Non-Hormonal
-
Delivery type:
- Vaginal - Other
-
Intended Duration:
- Not Yet Determined
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Dare BioScience Inc.
Details
- API: Not Yet Public
- Target: Not Yet Public
-
Mechanism of Action:
- Not Yet Determined
- Inactive Materials: Not Yet Public
- Regimen: Not Yet Public
- MPT: Not Yet Determined
- Promising Attributes: Not Yet Public
Product Status
Active/Recent Pre-Clinical Evaluation
History
2024: Dare Bioscience announces receipt of $10.7M grant to derisk development of a non-hormonal intravaginal contraceptive, intended for use in low- and middle-income settings.